An intranasal administration of <i>Lactococcus lactis</i> strains expressing recombinant interleukin‐10 modulates acute allergic airway inflammation in a murine model

Abstract

Treatment with L. lactis producing recombinant IL-10 used in this study (LL-CYT and LL-SEC) modulated experimental airway inflammation in the mouse model independently of Treg cells. Additionally, the LL-CYT strain was more efficient in the suppression of lung inflammation.